Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

US RETT ANAVEX2-73-RS-001 TRIAL PRIMARY OUTCOME MEASURES:

https://clinicaltrials.gov/ct2/show/NCT03758924?term=ANAVEX&draw=2&rank=7

Primary Outcome Measures:

1. Incidence of Adverse Events [ Time Frame: 7 weeks ]
Incidence of Adverse Events

2. Maximum Plasma Concentration [Cmax] of ANAVEX2-73 [ Time Frame: 7 weeks ]
PK of ANAVEX2-73 and metabolite

3. Area Under the Curve [AUC] of ANAVEX2-73 [ Time Frame: 7 weeks ]
PK of ANAVEX2-73 and metabolite

4. Lipid panel [ Time Frame: 7 weeks ]
Significant laboratory findings

GOOD LUCK AND GOD BLESS!!!!